HIV reservoirs and latency models.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Virology

• Publication date

  2011-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virol.2010.12.041PMID 21284992PMCID PMC3618966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 19th Conference on Retroviruses and Opportunistic Infections

  2012cited by this paper
• Elite Suppressors Harbor Low Levels of Integrated HIV DNA and High Levels of 2-LTR Circular HIV DNA Compared to HIV+ Patients On and Off HAART

  2011cited by this paper
• Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs.

  2011cited by this paper
• Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells.

  2011cited by this paper
• Increased Monocyte Turnover from Bone Marrow Correlates with Severity of SIV Encephalitis and CD163 Levels in Plasma

  2010cited by this paper
• No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.

  2010cited by this paper
• Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.

  2010cited by this paper
• Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States

  2010cited by this paper
• The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

  2010cited by this paper
• HIV‐1 regulation of latency in the monocyte‐macrophage lineage and in CD4+ T lymphocytes

  2010cited by this paper
• Establishment of HIV Latency in Primary CD4+ Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction

  2010influential reference
• HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals

  2010cited by this paper
• Mechanisms of HIV Latency: an Emerging Picture of Complexity

  2010influential reference
• R5 HIV env and Vesicular Stomatitis Virus G Protein Cooperate To Mediate Fusion to Naïve CD4+ T Cells

  2010cited by this paper
• HIV reservoirs, latency, and reactivation: prospects for eradication.

  2010cited by this paper
• Quiescent T cells and HIV: an unresolved relationship

  2010influential reference
• Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy.

  2010cited by this paper
• Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton

  2010influential reference
• Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year.

  2010cited by this paper
• Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

  2010cited by this paper
• HIV–1 Infects Multipotent Progenitor Cells Causing Cell Death and Establishing Latent Cellular Reservoirs

  2010cited by this paper
• Establishment of drug-resistant HIV-1 in latent reservoirs.

  2009influential reference
• In Vivo Analysis of Dendritic Cell Development and Homeostasis

  2009cited by this paper
• Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

  2009influential reference
• Human Immunodeficiency Virus Integrates Directly into Naïve Resting CD4+ T Cells but Enters Naïve Cells Less Efficiently than Memory Cells

  2009cited by this paper
• Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4+ T Cells

  2009cited by this paper
• The CXCR4-Tropic Human Immunodeficiency Virus Envelope Promotes More-Efficient Gene Delivery to Resting CD4+ T Cells than the Vesicular Stomatitis Virus Glycoprotein G Envelope

  2009cited by this paper
• HIV integration site distributions in resting and activated CD4+ T cells infected in culture

  2009cited by this paper
• HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

  2009influential reference
• Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

  2009influential reference
• Viral Sanctuaries during Highly Active Antiretroviral Therapy in a Nonhuman Primate Model for AIDS

  2009influential reference
• HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

  2009cited by this paper
• Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.

  2009cited by this paper
• The level of monocyte turnover predicts disease progression in the macaque model of AIDS.

  2009cited by this paper
• Antiretroviral Tissue Kinetics: In Vivo Imaging Using Positron Emission Tomography

  2009cited by this paper
• Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy

  2009cited by this paper
• Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR.

  2009cited by this paper
• The utilization of humanized mouse models for the study of human retroviral infections

  2009influential reference
• Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs

  2009cited by this paper
• Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells.

  2009influential reference
• Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome

  2009cited by this paper
• Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

  2009cited by this paper
• Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies

  2009cited by this paper
• The HIV Envelope but Not VSV Glycoprotein Is Capable of Mediating HIV Latent Infection of Resting CD4 T Cells

  2009influential reference
• Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors

  2009cited by this paper
• Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation

  2009influential reference
• Novel humanized murine models for HIV research

  2009cited by this paper
• Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4+ T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy

  2009cited by this paper
• Elucidating the elite: mechanisms of control in HIV-1 infection.

  2009cited by this paper
• A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy

  2009influential reference
• The Challenge of Finding a Cure for HIV Infection

  2009cited by this paper
• Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

  2008influential reference
• Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

  2008influential reference
• Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.

  2008influential reference
• HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells.

  2008influential reference
• Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

  2008cited by this paper
• A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients.

  2008cited by this paper
• An In Vitro System to Model the Establishment and Reactivation of HIV-1 Latency

  2008cited by this paper
• Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.

  2008cited by this paper
• Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy

  2008cited by this paper
• HIV rebounds from latently infected cells, rather than from continuing low-level replication

  2008cited by this paper
• CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection.

  2007cited by this paper
• Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

  2007cited by this paper
• Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4+ T Cells

  2007cited by this paper
• HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.

  2007cited by this paper
• Experimental approaches to the study of HIV-1 latency

  2007influential reference
• Origin of dendritic cells in peripheral lymphoid organs of mice

  2007cited by this paper
• Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1

  2007cited by this paper
• Immediate Activation Fails To Rescue Efficient Human Immunodeficiency Virus Replication in Quiescent CD4+ T Cells

  2007influential reference
• CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency.

  2007influential reference
• The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo1

  2007cited by this paper
• Apoptotic Killing of HIV-1–Infected Macrophages Is Subverted by the Viral Envelope Glycoprotein

  2007cited by this paper
• Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus

  2007influential reference
• Dendritic-cell interactions with HIV: infection and viral dissemination

  2006cited by this paper
• Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells

  2006cited by this paper
• R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells.

  2006cited by this paper
• Retroviral infection of non-dividing cells: old and new perspectives.

  2006cited by this paper
• Rapid Expression of Human Immunodeficiency Virus following Activation of Latently Infected Cells

  2006cited by this paper
• The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.

  2006cited by this paper
• Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells

  2006influential reference
• HUMAN IMMUNODEFICIENCY VIRUS HIV-Infected Individuals Receiving Effective Antiviral Therapy for Extended Periods of Time Continually Replenish Their Viral Reservoir

  2006cited by this paper
• A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes.

  2006cited by this paper
• CD4+ count-guided interruption of antiretroviral treatment.

  2006cited by this paper
• The γc-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells

  2006cited by this paper
• Depletion of Latent HIV-1 Infection In Vivo: A Proof-of-Concept Study

  2006cited by this paper
• Novel Pathway for Induction of Latent Virus from Resting CD4+ T Cells in the Simian Immunodeficiency Virus/Macaque Model of Human Immunodeficiency Virus Type 1 Latency

  2006influential reference
• Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors

  2006cited by this paper
• Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4+ T Cells in the Absence of Activating Stimuli

  2005cited by this paper
• Perils at mucosal front lines for HIV and SIV and their hosts

  2005cited by this paper
• Macrophages archive HIV‐1 virions for dissemination in trans

  2005cited by this paper
• Host factors regulating post-integration latency of HIV.

  2005cited by this paper
• Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

  2005cited by this paper
• Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

  2005cited by this paper
• HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

  2005cited by this paper
• Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.

  2005cited by this paper
• Alu-LTR real-time nested PCR assay for quantifying integrated HIV-1 DNA.

  2005cited by this paper
• Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.

  2005cited by this paper
• Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells

  2005influential reference
• IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

  2005cited by this paper
• T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis

  2004cited by this paper

• Transcription of HIV-1 at sites of intact latent provirus integration

  2024cites this paper
• Quantum mechanical analysis of newly synthesized HIV-1 protease inhibitors: evaluation of wild-type and resistant strain binding interactions.

  2024cites this paper
• The Proviral Reservoirs of Human Immunodeficiency Virus (HIV) Infection

  2024cites this paper
• Stability and bifurcations for a 3D Filippov SEIS model with limited medical resources

  2024cites this paper
• Transcription of HIV-1 at sites of intact latent provirus integration

  2024cites this paper
• Exosomes multifunctional roles in HIV-1: insight into the immune regulation, vaccine development and current progress in delivery system

  2023cites this paper
• Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency

  2023cites this paper
• HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication

  2023cites this paper
• HIV persistence: silence or resistance?

  2023cites this paper
• Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays

  2022cites this paper
• Cell‐to‐cell transmission of HIV‐1 from provirus‐activated cells to resting naïve and memory human primary CD4 T cells is highly efficient and requires CD4 and F‐actin but not chemokine receptors

  2022influential citation
• Host variation in type I interferon signaling genes (MX1), CCR5Δ32, and MHC class I alleles in treated HIV+ non-controllers predict viral reservoir size

  2022cites this paper
• Bimodal Expression Patterns, and Not Viral Burst Sizes, Predict the Effects of Vpr on HIV-1 Proviral Populations in Jurkat Cells

  2022cites this paper
• Analysis of the Interaction Between HIV and Periodontopathic Bacteria That Reactivates HIV Replication in Latently Infected Cells.

  2021cites this paper
• Highly active antiretroviral therapy conjugated silver nanoparticle ameliorates testicular injury in type-2 diabetic rats

  2021cites this paper
• Host Variation in Interferon, MHC Class I, Glycosylation, and Viral Transcription Genes Predict HIV Persistence

  2021cites this paper
• Vpr shapes the proviral landscape and polyclonal HIV-1 reactivation patterns in cultured cells

  2021cites this paper
• Effect of Major Splice Site deletions in Latency and Infectivity of 8 HIV Constructs

  2021cites this paper
• HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

  2021cites this paper
• Periodontal Pathogens: Methods and Protocols

  2021cites this paper
• Feasibility and safety of research sigmoid colon biopsy in a cohort of Thai men who have sex with men with acute HIV-1

  2020cites this paper
• Identification of novel cellular factors involved in HIV-1 latency

  2020cites this paper
• Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

  2020cites this paper
• HIV-specific T-cell responses reflect substantive in vivo interactions with infected cells despite long-term therapy

  2020cites this paper
• Immunological approaches to HIV cure.

  2020cites this paper
• Stability and Hopf bifurcation of a delayed virus infection model with latently infected cells and Beddington–DeAngelis incidence

  2020cites this paper
• Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir.

  2019cites this paper
• HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals

  2019cites this paper
• Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies.

  2019cites this paper
• Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors

  2019cites this paper
• Limitations of dual‐fluorescent HIV reporter viruses in a model of pre‐activation latency

  2019cites this paper
• Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy

  2019cites this paper
• The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like

  2019cites this paper
• Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis

  2019cites this paper
• Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review).

  2019cites this paper
• Barriers for HIV Cure: The Latent Reservoir

  2018cites this paper
• IL-2 Inducible Kinase ITK is Critical for HIV-1 Infection of Jurkat T-cells

  2018cites this paper
• Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs

  2018cites this paper
• HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy

  2018cites this paper
• What do we measure when we measure cell-associated HIV RNA

  2018cites this paper
• HIV-1-Infected CD4+ T Cells Facilitate Latent Infection of Resting CD4+ T Cells through Cell-Cell Contact.

  2018cites this paper
• Phylogenetic approach to recover integration dates of latent HIV sequences within-host

  2018cites this paper
• Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in Thailand

  2018cites this paper
• Roles of CDKs in RNA polymerase II transcription of the HIV-1 genome

  2018cites this paper
• Strength of T cell signaling regulates HIV-1 replication and establishment of latency

  2018cites this paper
• Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity

  2017cites this paper
• The Relevance of Post-Transcriptional Mechanisms in HIV Latency Reversal.

  2017cites this paper
• Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation

  2017cites this paper
• On the way to find a cure: Purging latent HIV‐1 reservoirs

  2017cites this paper
• Insights into the molecular and biological features of the dUTPase-related gene of bovine immunodeficiency virus.

  2017cites this paper
• Role and modulation of drug transporters in HIV-1 therapy.

  2016cites this paper
• Modelling HIV dynamics and evolution : prospects for viral control

  2016cites this paper
• Caracterização de variantes virais de HIV-1 em indivíduos soropositivos com perfil de controle da progressão para a AIDS e da replicação viralavaliação da ocorrência de variantes de escape da resposta imune

  2016cites this paper
• [Research advances in evaluation and measurement techniques of latent human immunodeficiency virus reservoirs].

  2016cites this paper
• Two cellular microRNAs, miR-196b and miR-1290, contribute to HIV-1 latency.

  2015cites this paper
• Persistent Production of an Integrase-Deleted HIV-1 Variant with No Resistance Mutation and Wild-Type Proviral DNA in a Treated Patient

  2015cites this paper
• Immuno-modulatory strategies for reduction of HIV reservoir cells.

  2015cites this paper
• Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA

  2015cites this paper
• Investigation of the Role of Myeloid and T Cells in Human Immunodeficiency Virus (HIV) Infection and Persistence in Vivo

  2015cites this paper
• Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells

  2015cites this paper
• Delivery of long-acting injectable antivirals: best approaches and recent advances

  2015influential citation
• Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch

  2015cites this paper
• Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection

  2015cites this paper
• Global dynamics of a class of HIV-1 infection models with latently infected cells

  2015cites this paper
• Bioinformatics and HIV Latency

  2015cites this paper
• Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions

  2014cites this paper
• Entry of HIV in Primary Human Resting CD4+ T Cells Pretreated with the Chemokine CCL19

  2014cites this paper
• Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection.

  2014cites this paper
• Complement-Mediated Lysis of Latently Triggers Antibody-Dependent Provirus Activation Plus CD59 Blockage

  2014cites this paper
• HIV-1 Complement-Mediated Lysis of Latently Triggers Antibody-Dependent Provirus Activation Plus CD 59 Blockage

  2014cites this paper
• Dilazep synergistically reactivates latent HIV-1 in latently infected cells Hanxian ZengSijie LiuPengfei WangXiying QuHaiyan Ji • Xiaohui WangXiaoli ZhuZhishuo SongXinyi YangZhongjun Ma •

  2014cites this paper
• Reduced evolutionary rates in HIV-1 reveal extensive latency periods among replicating lineages

  2014cites this paper
• Genome-wide analysis of histone modifications in latently HIV-1 infected T cells

  2014cites this paper
• Reservorios del virus de inmunodeficiencia humana tipo 1 (VIH-1): mecanismos de latencia y estrategias terapéuticas

  2014cites this paper
• Principles of HIV Gene Therapy

  2014cites this paper
• Dilazep synergistically reactivates latent HIV-1 in latently infected cells

  2014cites this paper
• Gene Therapy for HIV

  2014cites this paper
• Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model

  2014cites this paper
• Immunity to HIV in Early Life

  2014cites this paper
• Provirus Activation Plus CD59 Blockage Triggers Antibody-Dependent Complement-Mediated Lysis of Latently HIV-1–Infected Cells

  2014cites this paper
• Roles of HIV-1 capsid in viral replication and immune evasion.

  2014cites this paper
• In Vivo Functions of CPSF6 for HIV-1 as Revealed by HIV-1 Capsid Evolution in HLA-B27-Positive Subjects

  2014cites this paper
• An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients

  2013cites this paper
• Recent developments in human immunodeficiency virus-1 latency research

  2013cites this paper
• Stability and Hopf Bifurcation in an HIV-1 Infection Model with Latently Infected Cells and Delayed Immune Response

  2013cites this paper
• As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.

  2013cites this paper
• State of genomics and epigenomics research in the perspective of HIV cure

  2013cites this paper
• Cellular and molecular mechanisms involved in the establishment of HIV-1 latency

  2013cites this paper
• Feline immunodeficiency virus latency

  2013cites this paper
• A Doubly Fluorescent HIV-1 Reporter Shows that the Majority of Integrated HIV-1 Is Latent Shortly after Infection

  2013cites this paper
• Altering cell death pathways as an approach to cure HIV infection

  2013cites this paper
• HIV-1 transcription and latency: an update

  2013cites this paper
• Cell signalling and feline immunodeficiency virus growth and latency

  2013cites this paper
• Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.

  2013cites this paper
• The interaction of HIV with cellular trafficking pathways

  2013cites this paper
• Novel Approaches for the Eradication Of HIV Latently Infected Cells

  2013cites this paper
• As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.

  2013cites this paper
• Cell-associated HIV RNA: a dynamic biomarker of viral persistence

  2013cites this paper
• Follicular Dendritic Cells, Human Immunodeficiency Virus Type-1, And Alpha-1-Antitrypsin

  2012cites this paper
• Controlling the HIV/AIDS epidemic: current status and global challenges

  2012cites this paper